Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

Published:1998-08-27 Issue:9 Volume:339 Page:591-598
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Cavé Hélène,van der Werff ten Bosch Jutte,Suciu Stefan,Guidal Christine,Waterkeyn Christine,Otten Jacques,Bakkus Marleen,Thielemans Kris,Grandchamp Bernard,Vilmer Etienne,Nelken Brigitte,Fournier Martine,Boutard Patrick,Lebrun Emmanuel,Méchinaud Françoise,Garand Richard,Robert Alain,Dastugue Nicole,Plouvier Emmanuel,Racadot Evelyne,Ferster Alice,Gyselinck Jan,Fenneteau Odile,Duval Michel,Solbu Gabriel,Manel Anne-Marie

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJM199808273390904

Cited by 644 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Throughput Sequencing Revealing BCR and TCR Repertoires as Potential Prognostic Biomarkers for Pediatric Patients with B-ALL;Current Genomics;2024-08-21

2. Bayesian Modelling of Response to Therapy and Drug-Sensitivity in Acute Lymphoblastic Leukemia;Statistics in Biosciences;2024-05-29

3. Investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment;Nature Communications;2024-05-01

4. The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-04-30

5. The Use of Flow Cytometry for MRD Detection of B- and T-ALL in Pediatric Patients;Reference Module in Biomedical Sciences;2024